Healthcare provider profile · identity verified

Haley Smith Hammond, MD

Family Practice · BEDFORD, VA · NPI 1699304162

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	190	76
Amlodipine Besylate	Amlodipine Besylate	160	74
Omeprazole	Omeprazole	125	44
Levothyroxine Sodium	Levothyroxine Sodium	124	54
Losartan Potassium	Losartan Potassium	116	54
Hydrochlorothiazide	Hydrochlorothiazide	89	37
Furosemide	Furosemide	84	35
Lisinopril	Lisinopril	84	36
Gabapentin	Gabapentin	76	26
Montelukast Sodium	Montelukast Sodium	72	25
Rosuvastatin Calcium	Rosuvastatin Calcium	69	29
Metoprolol Tartrate	Metoprolol Tartrate	56	23
Meloxicam	Meloxicam	52	26
Metformin Hcl	Metformin Hcl	52	19
Metoprolol Succinate	Metoprolol Succinate	52	20
Eliquis	Apixaban	51	17
Pantoprazole Sodium	Pantoprazole Sodium	49	26
Metformin Hcl Er	Metformin Hcl	48	19
Albuterol Sulfate Hfa	Albuterol Sulfate	47	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	12
Pravastatin Sodium	Pravastatin Sodium	47	18
Tamsulosin Hcl	Tamsulosin Hcl	47	20
Famotidine	Famotidine	46	25
Spironolactone	Spironolactone	45	18
Sertraline Hcl	Sertraline Hcl	44	13
Allopurinol	Allopurinol	41	20
Tizanidine Hcl	Tizanidine Hcl	41	12
Pregabalin	Pregabalin	40	12
Ozempic	Semaglutide	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	19
Prednisone	Prednisone	37	29
Fluticasone Propionate	Fluticasone Propionate	35	21
Potassium Chloride	Potassium Chloride	35	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	30
Buspirone Hcl	Buspirone Hcl	34	16
Diclofenac Sodium	Diclofenac Sodium	34	16
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Cephalexin	Cephalexin	32	25
Lorazepam	Lorazepam	32	suppressed
Simvastatin	Simvastatin	32	13
Tramadol Hcl	Tramadol Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Glimepiride	Glimepiride	30	14
Methocarbamol	Methocarbamol	28	12
Trazodone Hcl	Trazodone Hcl	28	13
Lovastatin	Lovastatin	27	13
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Azithromycin	Azithromycin	25	24
Warfarin Sodium	Warfarin Sodium	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	15
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Carvedilol	Carvedilol	23	13
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	13
Alendronate Sodium	Alendronate Sodium	21	suppressed
Felodipine Er	Felodipine	20	11
Januvia	Sitagliptin Phosphate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Lactulose	Lactulose	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Methylprednisolone	Methylprednisolone	18	15
Synthroid	Levothyroxine Sodium	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Atenolol	Atenolol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Finasteride	Finasteride	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Cefdinir	Cefdinir	14	13
Naproxen	Naproxen	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Fluconazole	Fluconazole	12	11
Jardiance	Empagliflozin	12	suppressed
Nystatin	Nystatin	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error